Genic Co. Ltd (123330) - Total Assets
Based on the latest financial reports, Genic Co. Ltd (123330) holds total assets worth ₩56.53 Billion KRW (≈ $38.31 Million USD) as of December 2025. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. See Genic Co. Ltd (123330) shareholders funds for net asset value and shareholders' equity analysis.
Genic Co. Ltd - Total Assets Trend (2012–2025)
This chart illustrates how Genic Co. Ltd's total assets have evolved over time, based on quarterly financial data.
Genic Co. Ltd - Asset Composition Analysis
Current Asset Composition (December 2025)
Genic Co. Ltd's total assets of ₩56.53 Billion consist of 54.7% current assets and 45.4% non-current assets.
| Asset Category | Amount (KRW) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | ₩0.00 | 23.4% |
| Accounts Receivable | ₩6.20 Billion | 11.0% |
| Inventory | ₩11.06 Billion | 19.6% |
| Property, Plant & Equipment | ₩0.00 | 0.0% |
| Intangible Assets | ₩23.43 Million | 0.0% |
| Goodwill | ₩0.00 | 0.0% |
Asset Composition Trend (2012–2025)
This chart illustrates how Genic Co. Ltd's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. For live market cap, price, and company overview, see Genic Co. Ltd market cap and net worth.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Genic Co. Ltd's current assets represent 54.7% of total assets in 2025, an increase from 0.0% in 2012.
- Cash Position: Cash and equivalents constituted 23.4% of total assets in 2025, up from 11.5% in 2012.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 0.0% of total assets, unchanged from 0.0% in 2012.
- Asset Diversification: The largest asset category is inventory at 19.6% of total assets.
Genic Co. Ltd Competitors by Total Assets
Key competitors of Genic Co. Ltd based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Interparfums SA
PA:ITP
|
France | €992.48 Million |
|
NFC Corporation
KQ:265740
|
Korea | ₩86.21 Billion |
|
Chungdamglobal Co. Ltd.
KQ:362320
|
Korea | ₩217.61 Billion |
|
Skin Elements Ltd
AU:SKN
|
Australia | AU$2.01 Million |
|
Sanitar Co Ltd
TW:1817
|
Taiwan | NT$2.94 Billion |
|
Rigolleau SA
BA:RIGO
|
Argentina | AR$130.12 Billion |
|
Star Combo Pharma Ltd
AU:S66
|
Australia | AU$48.45 Million |
|
ZOONO Group Ltd
AU:ZNO
|
Australia | AU$6.01 Million |
Genic Co. Ltd - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 2.37 | 1.36 | 1.21 |
| Quick Ratio | 1.52 | 0.92 | 0.75 |
| Cash Ratio | 0.00 | 0.08 | 0.00 |
| Working Capital | ₩17.88 Billion | ₩5.55 Billion | ₩4.25 Billion |
Genic Co. Ltd - Advanced Valuation Insights
This section examines the relationship between Genic Co. Ltd's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 5.41 |
| Latest Market Cap to Assets Ratio | 0.00 |
| Asset Growth Rate (YoY) | 48.2% |
| Total Assets | ₩56.53 Billion |
| Market Capitalization | $148.21 Million USD |
Valuation Analysis
Below Book Valuation: The market values Genic Co. Ltd's assets below their book value (0.00x), which may indicate investor concerns about asset quality or future growth.
Rapid Asset Growth: Genic Co. Ltd's assets grew by 48.2% over the past year, indicating significant expansion of the company's resource base.
Annual Total Assets for Genic Co. Ltd (2012–2025)
The table below shows the annual total assets of Genic Co. Ltd from 2012 to 2025.
| Year | Total Assets | Change |
|---|---|---|
| 2025-12-31 | ₩56.53 Billion ≈ $38.31 Million |
+48.16% |
| 2024-12-31 | ₩38.16 Billion ≈ $25.86 Million |
+63.05% |
| 2023-12-31 | ₩23.40 Billion ≈ $15.86 Million |
-22.91% |
| 2022-12-31 | ₩30.36 Billion ≈ $20.57 Million |
-33.15% |
| 2021-12-31 | ₩45.41 Billion ≈ $30.77 Million |
-9.36% |
| 2020-12-31 | ₩50.10 Billion ≈ $33.95 Million |
-13.85% |
| 2019-12-31 | ₩58.15 Billion ≈ $39.41 Million |
-20.68% |
| 2018-12-31 | ₩73.31 Billion ≈ $49.68 Million |
-21.49% |
| 2017-12-31 | ₩93.38 Billion ≈ $63.28 Million |
-8.06% |
| 2016-12-31 | ₩101.56 Billion ≈ $68.83 Million |
+16.73% |
| 2015-12-31 | ₩87.01 Billion ≈ $58.97 Million |
+15.24% |
| 2014-12-31 | ₩75.50 Billion ≈ $51.17 Million |
+16.25% |
| 2013-12-31 | ₩64.95 Billion ≈ $44.01 Million |
+8.13% |
| 2012-12-31 | ₩60.07 Billion ≈ $40.71 Million |
-- |
About Genic Co. Ltd
Genic Co., Ltd. researches, develops, manufactures, and sells cosmetics and pharmaceuticals in South Korea and internationally. The company provides hydrogel masks, sheet masks, cream wrapping masks, mud masks, and bio cellulose masks; nose patch, eye patch, body patch, eye gel, lifting patch, and outdoor patches; cleanser, toner, lotion, serum, cream, sunscreen, and cleansing/soothing/oil pad; a… Read more